title: Health Care Costs in Patients Treated with Ipilimumab for Advanced Melanoma Results of a Retrospective Chart Review.
authors.affiliation: University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
authors.forename: A
authors.initials: A
authors.lastname: Tarhini
authors.affiliation: Bristol-Myers Squibb, Plainsboro, NJ, USA.
authors.forename: A S
authors.initials: AS
authors.lastname: Rao
authors.affiliation: Pharmerit International, Bethesda, MD, USA.
authors.forename: S
authors.initials: S
authors.lastname: Corman
authors.affiliation: Pharmerit US Bethesda, Bethesda, MD, USA.
authors.forename: M
authors.initials: M
authors.lastname: Botteman
authors.affiliation: Pharmerit US Bethesda, Bethesda, MD, USA.
authors.forename: X
authors.initials: X
authors.lastname: Ji
authors.affiliation: Pharmerit International, Bethesda, MD, USA.
authors.forename: S
authors.initials: S
authors.lastname: Mehta
authors.affiliation: Seattle Cancer Care Alliance, Seattle, WA, USA.
authors.forename: K
authors.initials: K
authors.lastname: Margolin